Literature DB >> 22419096

Protein kinase GSK3β regulates tumor suppressor Pdcd4 expression in lung cancer cells.

P N Vikhreva1, E V Korobko, I V Korobko.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22419096     DOI： 10.1134/S1607672912010176

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  9 in total

1.  S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth.

Authors:  N Valerio Dorrello; Angelo Peschiaroli; Daniele Guardavaccaro; Nancy H Colburn; Nicholas E Sherman; Michele Pagano
Journal:  Science       Date:  2006-10-20       Impact factor: 47.728

2.  A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation.

Authors:  H S Yang; A P Jansen; R Nair; K Shibahara; A K Verma; J L Cmarik; N H Colburn
Journal:  Oncogene       Date:  2001-02-08       Impact factor: 9.867

3.  Akt phosphorylates and regulates Pdcd4 tumor suppressor protein.

Authors:  Alexey Palamarchuk; Alexey Efanov; Vadim Maximov; Rami I Aqeilan; Carlo M Croce; Yuri Pekarsky
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

4.  MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand.

Authors:  Danish Sayed; Minzhen He; Chull Hong; Shumin Gao; Shweta Rane; Zhi Yang; Maha Abdellatif
Journal:  J Biol Chem       Date:  2010-04-19       Impact factor: 5.157

5.  Inflammation-induced loss of Pdcd4 is mediated by phosphorylation-dependent degradation.

Authors:  Tobias Schmid; Magdalena M Bajer; Johanna S Blees; Lisa K Eifler; Larissa Milke; Daniela Rübsamen; Kathrin Schulz; Andreas Weigert; Alyson R Baker; Nancy H Colburn; Bernhard Brüne
Journal:  Carcinogenesis       Date:  2011-07-18       Impact factor: 4.944

6.  Pdcd4 protein and mRNA level alterations do not correlate in human lung tumors.

Authors:  Svetlana V Kalinichenko; Eugene P Kopantzev; Elena V Korobko; Irina V Palgova; Larisa E Zavalishina; Maria V Bateva; Andrey N Petrov; Georgii A Frank; Eugene D Sverdlov; Igor V Korobko
Journal:  Lung Cancer       Date:  2008-05-23       Impact factor: 5.705

7.  Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion.

Authors:  Tobias Schmid; Aaron P Jansen; Alyson R Baker; Glenn Hegamyer; John P Hagan; Nancy H Colburn
Journal:  Cancer Res       Date:  2008-02-22       Impact factor: 12.701

Review 8.  An emerging strategy for cancer treatment targeting aberrant glycogen synthase kinase 3 beta.

Authors:  Katsuyoshi Miyashita; Mitsutoshi Nakada; Abbas Shakoori; Yasuhito Ishigaki; Takeo Shimasaki; Yoshiharu Motoo; Kazuyuki Kawakami; Toshinari Minamoto
Journal:  Anticancer Agents Med Chem       Date:  2009-12       Impact factor: 2.505

Review 9.  WNT signaling in lung disease: a failure or a regeneration signal?

Authors:  Melanie Königshoff; Oliver Eickelberg
Journal:  Am J Respir Cell Mol Biol       Date:  2009-03-27       Impact factor: 6.914
  9 in total
  1 in total

1.  Ethanol-induced transcriptional activation of programmed cell death 4 (Pdcd4) is mediated by GSK-3β signaling in rat cortical neuroblasts.

Authors:  Amanjot Kaur Riar; Madhusudhanan Narasimhan; Mary Latha Rathinam; Dhanashree Vedpathak; Srinivas Mummidi; George I Henderson; Lenin Mahimainathan
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.